12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Thursday's intraday session, several health care stocks experienced significant price movements. Gainers included ThermoGenesis Holdings, GT Biopharma, AcelRx Pharmaceuticals, CVRx, Navidea Biopharmaceutical, and LENSAR. Losers included Precipio, First Wave BioPharma, Kezar Life Sciences, Eloxx Pharmaceuticals, Coeptis Therapeutics, and PolarityTE.
June 08, 2023 | 5:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AcelRx Pharmaceuticals shares increased by 17.42% to $1.28 during Thursday's regular session.
AcelRx Pharmaceuticals experienced a significant increase in share price, which could lead to short-term gains for investors.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
CVRx stock rose 15.17% to $14.72 during Thursday's regular session.
CVRx experienced a significant increase in share price, which could lead to short-term gains for investors.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
GT Biopharma shares moved upwards by 20.54% to $0.39 during Thursday's regular session.
GT Biopharma experienced a significant increase in share price, which could lead to short-term gains for investors.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
LENSAR stock moved upwards by 14.75% to $3.81 during Thursday's regular session.
LENSAR experienced a significant increase in share price, which could lead to short-term gains for investors.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Navidea Biopharmaceutical stock rose 14.87% to $0.09 during Thursday's regular session.
Navidea Biopharmaceutical experienced a significant increase in share price, which could lead to short-term gains for investors.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
ThermoGenesis Holdings shares moved upwards by 21.1% to $1.49 during Thursday's regular session.
ThermoGenesis Holdings experienced a significant increase in share price, which could lead to short-term gains for investors.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Coeptis Therapeutics shares fell 12.47% to $1.61 during Thursday's regular session.
Coeptis Therapeutics experienced a significant decrease in share price, which could lead to short-term losses for investors.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Eloxx Pharmaceuticals stock declined by 12.95% to $6.12 during Thursday's regular session.
Eloxx Pharmaceuticals experienced a significant decrease in share price, which could lead to short-term losses for investors.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
First Wave BioPharma shares declined by 17.47% to $1.37 during Thursday's regular session.
First Wave BioPharma experienced a significant decrease in share price, which could lead to short-term losses for investors.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Kezar Life Sciences shares declined by 14.15% to $2.5 during Thursday's regular session.
Kezar Life Sciences experienced a significant decrease in share price, which could lead to short-term losses for investors.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Precipio stock decreased by 27.5% to $0.49 during Thursday's regular session.
Precipio experienced a significant decrease in share price, which could lead to short-term losses for investors.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
PolarityTE shares declined by 12.43% to $0.25 during Thursday's regular session.
PolarityTE experienced a significant decrease in share price, which could lead to short-term losses for investors.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100